Search by Drug Name or NDC

NDC 68788-8127-02 BENZONATATE 200 mg/1 Details

BENZONATATE 200 mg/1

BENZONATATE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is BENZONATATE.

MedlinePlus Drug Summary

Benzonatate is used to relieve cough. Benzonatate is in a class of medications called antitussives (cough suppressants). It works by reducing the cough reflex in the lungs and air passages.

Related Packages: 68788-8127-02
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Benzonatate

Product Information

NDC	68788-8127
Product ID	68788-8127_c24a9ef9-d836-485d-95a9-cc87294e7dc0
Associated GPIs	43102010000110
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	BENZONATATE
Proprietary Name Suffix	n/a
Non-Proprietary Name	BENZONATATE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	200
Active Ingredient Units	mg/1
Substance Name	BENZONATATE
Labeler Name	Preferred Pharmaceuticals Inc.
Pharmaceutical Class	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA040682
Listing Certified Through	2024-12-31

Package

NDC 68788-8127-02 (68788812702)

Pricing Information	N/A
NDC Package Code	68788-8127-2
Billing NDC	68788812702
Package	20 CAPSULE in 1 BOTTLE (68788-8127-2)
Marketing Start Date	2022-01-17
NDC Exclude Flag	N